Phase III, two arm, multi-centre, open label, parallel-group randomised designed clinical investigation of the use of a personalised early warning decision support system to predict and prevent acute exacerbations of chronic obstructive pulmonary disease: ‘Predict & Prevent AECOPD’ – study protocol

INTRODUCTION: With 65 million cases globally, chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death and imposes a heavy burden on patients’ lives and healthcare resources worldwide. Around half of all patients with COPD have frequent (≥2 per year) acute exacerbations of C...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Dalbir, Mehta, Rajnikant L, Jarrett, Hugh, Jowett, Sue, Gale, Nicola K, Turner, Alice M, Spiteri, Monica, Patel, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016266/
https://www.ncbi.nlm.nih.gov/pubmed/36914185
http://dx.doi.org/10.1136/bmjopen-2022-061050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016266/
https://www.ncbi.nlm.nih.gov/pubmed/36914185
http://dx.doi.org/10.1136/bmjopen-2022-061050

Ejemplares similares